ARRT Bone Densitometry (BD) Practice Exam

The FRAX tool is designed specifically to assess the 10-year probability of a major osteoporotic fracture or hip fracture in individuals based on several clinical risk factors and bone mineral density (BMD) measurements. By utilizing personal and clinical data, such as age, sex, weight, height, prior fracture history, parental history of hip fracture, smoking status, corticosteroid use, alcohol consumption, and the presence of certain diseases, the FRAX tool provides insight into a patient's risk for osteoporosis-related fractures.

Osteoporosis is characterized by decreased bone density and increased fragility, making individuals more susceptible to fractures. The FRAX tool essentially identifies individuals who may have osteoporosis or are at high risk for developing it, thus facilitating timely intervention and management.

On the other hand, arthritis, rheumatism, and osteomalacia are not conditions that the FRAX tool is specifically designed to evaluate. While they may have some correlation with bone health, they do not specifically relate to the assessment of osteoporosis risk in the way that the FRAX tool does. Therefore, the identification of osteoporosis using the FRAX tool is a critical aspect of understanding and managing bone health in patients.